Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumorsJennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial TumorsDejan Juric, Rodrigo Dienstmann, Andres Cervantes, et al.Molecular Cancer Therapeutics|October 22, 2017
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid TumorsElaine T Lam, S Gail Eckhardt, Wells Messersmith, et al.Investigational New Drugs|May 21, 2017
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase CKhaldoun Almhanna, David Wright, Teresa Macarulla Mercade, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic AdenocarcinomaMiles Piper, Benjamin Van Court, Adam Mueller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
An in vivo platform for translational drug development in pancreatic cancerBelen Rubio-Viqueira, Antonio Jimeno, George Cusatis, et al.Frontiers in Oncology|March 29, 2021
Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction CancersNoah Kastelowitz, Megan D Marsh, Martin McCarter, et al.Cancer Immunology Research|October 18, 2017
A Blueprint to Advance Colorectal Cancer ImmunotherapiesDung T Le, Vanessa M Hubbard-Lucey, Michael A Morse, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Colon cancer, version 3.2014Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.BJS Open|June 9, 2026
Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective studyThomas F Stoop, Chiara Croce, Hiroyuki Ishida, et al.Pageof 5